Browse

In vivo hyperoxic preconditioning prevents myocardial infarction by expressing bcl-2

DC Field Value Language
dc.contributor.authorChoi, Hong-
dc.contributor.authorKim, Sang-Hyun-
dc.contributor.authorChun, Yang-Sook-
dc.contributor.authorCho, Young-Suk-
dc.contributor.authorPark, Jong-Wan-
dc.contributor.authorKim, Myung-Suk-
dc.date.accessioned2010-01-19T14:08:10Z-
dc.date.available2010-01-19T14:08:10Z-
dc.date.issued2006-03-28-
dc.identifier.citationExp Biol Med (Maywood). 2006 Apr;231(4):463-72.en
dc.identifier.issn1535-3702 (Print)-
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16565442-
dc.identifier.urihttp://hdl.handle.net/10371/38219-
dc.description.abstractPreconditioning with oxidative stress has been demonstrated in vitro to stimulate the cellular adaptation to subsequent severe oxidative stress. However, it is uncertain whether this preconditioning works in vivo. In the present study, we examined in vivo the beneficial effect of oxidative preconditioning. After rats were pretreated with whole-body hyperoxygenation (100% O(2) at 3 atmosphere for 20 mins, four cycles with 20-min intermission), isolated hearts were subjected to 45-min ischemia followed by 90-min reperfusion. This hyperoxic preconditioning significantly reduced infarct size, cytochrome-c release, DNA fragmentation, and terminal deoxynucleotidyl transferase-mediated dUTD nick-end labeling-positive cell frequency in the left ventricle, biphasically with an early (30-min) and a delayed (48-hr) effect after the hyperoxygenation. Mechanistically, the NF-kappaB activity and Bcl-2 expression were enhanced in the hearts, and a NF-kappaB inhibitor, pyrrolidine dithiocarbamate, abolished the Bcl-2 induction as well as the infarct-limiting effect. An antioxidant, N-acetylcysteine, and protein kinase C (PKC) inhibitors chelerythrine and Go 6983 also blocked the preconditioning effects. These results indicate that hyperoxia induces myocardial tolerance against ischemia-reperfusion injury in association with Bcl-2 induction by NF-kappaB activation through reactive oxygen species and PKC-dependent signaling pathway.en
dc.language.isoenen
dc.publisherSociety for Experimental Biology and Medicineen
dc.subjectAnimalsen
dc.subjectDNA Fragmentationen
dc.subjectGene Expression Regulationen
dc.subject*Hyperoxiaen
dc.subjectIn Situ Nick-End Labelingen
dc.subjectMaleen
dc.subjectMyocardial Infarction/*prevention & controlen
dc.subjectMyocardial Reperfusion Injury/metabolismen
dc.subjectMyocardium/metabolismen
dc.subjectNF-kappa B/metabolismen
dc.subjectProto-Oncogene Proteins c-bcl-2/genetics/metabolismen
dc.subjectRNA, Messenger/metabolismen
dc.subjectRatsen
dc.subjectRats, Sprague-Dawleyen
dc.titleIn vivo hyperoxic preconditioning prevents myocardial infarction by expressing bcl-2en
dc.typeArticleen
dc.contributor.AlternativeAuthor최홍-
dc.contributor.AlternativeAuthor김상현-
dc.contributor.AlternativeAuthor전양숙-
dc.contributor.AlternativeAuthor조영석-
dc.contributor.AlternativeAuthor박종완-
dc.contributor.AlternativeAuthor김명석-
Appears in Collections:
College of Medicine/School of Medicine (의과대학/대학원)Molecular and Genomic Medicine (분자유전체의학전공)Journal Papers (저널논문_분자유전체의학전공)
Files in This Item:
There are no files associated with this item.
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse